With the greater use of MIAVR, there is a growing understanding of the outcomes following MIAVR compared with traditional aortic valve replacement (AVR) with median sternotomy, including survival ...

Transscatheter aortic valve replacement is a novel way to replace a diseased aortic valve without a median sternotomy. The first human TAVR was performed by Dr. Cribier in 2002. [33] There have ...